Data is currently being updated. Some features may be temporarily unstable.

Disease Profile

Parasitic

Babesiosis

巴贝西虫病

Babesiosis is a zoonotic parasitic infection caused by intraerythrocytic protozoa of the genus Babesia [1][2]. It is transmitted primarily by ticks, with less common transmission through blood transfusion and rare transmission via transplacental spread or organ transplantation [2]. Human illness ranges from asymptomatic or subclinical infection to severe, fulminant disease and death, and the syndrome can resemble malaria [1][2].

Definition

Babesiosis is an infection caused by intraerythrocytic parasites of the genus Babesia [2][1]. The condition is described as zoonotic and tick-transmitted, with human infection occurring despite the much broader range of Babesia species that infect domesticated and wild animals [1]. Source-backed detail on formal case definitions or species-specific distinctions is not yet available in the provided material [1].

Clinical features

Human babesiosis can present without symptoms or as subclinical infection, but it may also progress to severe, fulminant disease [1]. Reported clinical features resemble malaria, and the infection can be fatal in immunocompromised and older patients [2]. Because Babesia parasites invade red blood cells, babesiosis may be considered in the context of hemolytic illness, which can manifest with acute or chronic anemia, reticulocytosis, or jaundice [3][2]. Source-backed detail on the full symptom spectrum, timing, and complications is not yet available in the provided material [2][1].

Epidemiology

Human babesiosis is reported throughout the world, indicating a broad geographic distribution, but the incidence is highest in the Northeast and upper Midwestern United States [2]. The literature provided frames babesiosis as an emerging tick-borne disease and notes that increasing prevalence and transmission of tick-borne infections are important public-health issues [4]. Tick surveillance and tracking are described as useful for identifying areas of risk for transmission, while underdiagnosis makes the overall scope of tick-borne disease difficult to assess [4]. Source-backed detail on seasonality, specific reservoir hosts, and local outbreak patterns is not yet available in the provided material [2][4].

Transmission

Transmission occurs primarily through tick exposure [2][1]. Less common routes include blood transfusion, and rare routes include transplacental transmission and organ transplantation [2]. Source-backed detail on the specific tick species, environmental persistence, or person-to-person spread is not yet available in the provided material [2].

Risk groups

The sources specifically identify immunocompromised and older patients as groups in whom babesiosis can be fatal [2]. More generally, risk is linked to exposure to ticks and, less commonly, to transfusion or other non-vector routes of infection [2]. Source-backed detail on additional occupational, behavioral, or comorbidity-based risk groups is not yet available in the provided material [2].

Prevention

The provided sources emphasize the public-health importance of controlling tick populations and using tick surveillance and tracking to identify areas of transmission risk [4]. Awareness of tick-transmitted pathogens in specific locations is also described as important for detection and for selecting appropriate clinical response [4]. Source-backed detail on personal protective measures, chemoprophylaxis, or vaccination is not yet available in the provided material [4].

Surveillance note

In surveillance settings, babesiosis should be read as a tick-borne parasitic infection with a geographically broad but uneven distribution, including higher incidence in the Northeast and upper Midwestern United States [2]. The literature indicates that the disease may be underdiagnosed, so observed case counts may underestimate true burden [4]. Tick surveillance can help define areas of risk for transmission, while case recognition is informed by the possibility of asymptomatic, mild, or severe disease [4][1].

References
  1. 1 Babesiosis. Oxford Medicine Online. 2017. doi: 10.1093/med/9780199937837.003.0164. DOI: https://doi.org/10.1093/med/9780199937837.003.0164
  2. 2 Waked R et al. Human Babesiosis. Infect Dis Clin North Am. 2022 Sep. PMID: 36116841. doi: 10.1016/j.idc.2022.02.009. PubMed: https://pubmed.ncbi.nlm.nih.gov/36116841/
  3. 3 Madison-Antenucci S et al. Emerging Tick-Borne Diseases. Clin Microbiol Rev. 2020 Mar 18. PMID: 31896541. doi: 10.1128/CMR.00083-18. PubMed: https://pubmed.ncbi.nlm.nih.gov/31896541/
  4. 4 Dhaliwal G et al. Hemolytic anemia. Am Fam Physician. 2004 Jun 1. PMID: 15202694. PubMed: https://pubmed.ncbi.nlm.nih.gov/15202694/
  5. 5 Babesiosis. Microbial Zoonoses. 2022. doi: 10.1007/978-981-16-7204-0_15. DOI: https://doi.org/10.1007/978-981-16-7204-0_15
  6. 6 Babesiosis. Diseases of Cattle in the Tropics. 1981. doi: 10.1007/978-94-015-6895-1_35. DOI: https://doi.org/10.1007/978-94-015-6895-1_35
Coding Register
ICD-10
ICD-11
Key Statistics
Total cases
8K
Peak month
2023-07
Coverage
1 reporting countries · 2014-01-18 → 2024-12-28

Figure 1 | Full historical trajectories across all reporting countries.

Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.

Dataset Archive

Supplementary Data | Multi-country disease dataset

Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.

Rows
509
Data Version
2026-06-20
Coverage
Included metadata
Source links, scope, cadence

Source Register

Official sources and update cadences used to construct the downloadable dataset.

US
US CDC NNDSSweeklyapi

United States

CDC National Notifiable Diseases Surveillance System provisional data.

Official source
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.